
Overview
Mark Cadungog is an Oncologist in Newark, Delaware. Dr. Cadungog is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Vulvar Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Gastrostomy.
His clinical research consists of co-authoring 14 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4701 Ogletown Stanton Road, Suite 2335, Newark, DE 19713
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Temple Faculty Practice Plan Inc
Margaret Von-Mehren is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Von-Mehren is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Gastrointestinal Stromal Tumor, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Retroperitoneal Liposarcoma.
Skip Viragh Outpatient Cancer Center
Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Bone Tumor, and Ganglioneuroblastoma.
Abramson Cancer Center Radnor
Lee Hartner is a Hematologist and an Oncologist in Radnor, Pennsylvania. Dr. Hartner is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Retroperitoneal Liposarcoma, Liposarcoma, Gastrostomy, and Endoscopy. Dr. Hartner is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cervical CancerDr. Cadungog isDistinguished. Learn about Cervical Cancer.
- Endometrial CancerDr. Cadungog isDistinguished. Learn about Endometrial Cancer.
- Malignant Mixed Mullerian TumorDr. Cadungog isDistinguished. Learn about Malignant Mixed Mullerian Tumor.
- MelanomaDr. Cadungog isDistinguished. Learn about Melanoma.
- Ovarian CancerDr. Cadungog isDistinguished. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Cadungog isDistinguished. Learn about Ovarian Carcinosarcoma.
- Advanced
- Adult Soft Tissue SarcomaDr. Cadungog isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AngiomyomaDr. Cadungog isAdvanced. Learn about Angiomyoma.
- BRCA Positive Breast CancerDr. Cadungog isAdvanced. Learn about BRCA Positive Breast Cancer.
- Desmoplastic Small Round Cell TumorDr. Cadungog isAdvanced. Learn about Desmoplastic Small Round Cell Tumor.
- Eccrine PorocarcinomaDr. Cadungog isAdvanced. Learn about Eccrine Porocarcinoma.
- HER2 Negative Breast CancerDr. Cadungog isAdvanced. Learn about HER2 Negative Breast Cancer.
- Experienced
- Breast CancerDr. Cadungog isExperienced. Learn about Breast Cancer.
- DICER1 SyndromeDr. Cadungog isExperienced. Learn about DICER1 Syndrome.
- Familial Colorectal CancerDr. Cadungog isExperienced. Learn about Familial Colorectal Cancer.
- GastrostomyDr. Cadungog isExperienced. Learn about Gastrostomy.
- HemangiopericytomaDr. Cadungog isExperienced. Learn about Hemangiopericytoma.
- Hernia SurgeryDr. Cadungog isExperienced. Learn about Hernia Surgery.

